Antibiotics and growth factors in the management of fever and neutropenia in cancer patientsGARCIA-CARBONERO, Rocio; PAZ-ARES, Luis.Current opinion in hematology. 2002, Vol 9, Num 3, pp 215-221, issn 1065-6251Article

Vandetanib (100 mg) in Patients with Locally Advanced or Metastatic Hereditary Medullary Thyroid CancerROBINSON, Bruce G; PAZ-ARES, Luis; KREBS, Annetta et al.The Journal of clinical endocrinology and metabolism. 2010, Vol 95, Num 6, pp 2664-2671, issn 0021-972X, 8 p.Article

How could pharmacogenomics help improve patient survival?ROSELL, Rafael; FELIP, Enriqueta; PAZ-ARES, Luis et al.Lung cancer. 2007, Vol 57, issn 0169-5002, S35-S41, SUP2Article

Skin metastases from prostate adenocarcinomaPAZ-ARES, Luis; OLIVIA, Esther; CAREY, Robert W et al.Journal of clinical oncology. 2001, Vol 19, Num 7, pp 2099-2100, issn 0732-183XArticle

Review of a promising new agent: Pemetrexed disodiumPAZ-ARES, Luis; BEZARES, Susana; TABERNERO, José M et al.Cancer. 2003, Vol 97, Num 8, pp 2056-2063, issn 0008-543X, 8 p., SUPConference Paper

The role of pharmacogenomics in metastatic renal cell carcinomaCASTELLANO, Daniel; VIRIZUELA, Juan Antonio; CRUZ, Josefina et al.Cancer metastasis reviews. 2012, Vol 31, issn 0167-7659, S29-S32, SUP1Article

MicroRNA clusters: dysregulation in lung adenocarcinoma and COPDMOLINA-PINELO, Sonia; DOLORES PASTOR, M; PAZ-ARES, Luis et al.The European respiratory journal. 2014, Vol 43, Num 6, pp 1740-1749, issn 0903-1936, 10 p.Article

Screening for Epidermal Growth Factor Receptor Mutations in Lung CancerROSELL, Rafael; MORAN, Teresa; INSA, Amelia et al.The New England journal of medicine. 2009, Vol 361, Num 10, pp 958-967, issn 0028-4793, 10 p.Article

Customizing cisplatin based on quantitative excision repair cross-complementing 1 mRNA expression : A phase III trial in non-small-cell lung cancerCOBO, Manuel; ISLA, Dolores; FELIP, Enriqueta et al.Journal of clinical oncology. 2007, Vol 25, Num 19, pp 2747-2754, issn 0732-183X, 8 p.Article

Afatinib in the treatment of EGFR mutation-positive NSCLC ― A network meta-analysisPOPAT, Sanjay; MOK, Tony; YANG, James Chih-Hsin et al.Lung cancer. 2014, Vol 85, Num 2, pp 230-238, issn 0169-5002, 9 p.Article

Open-label, multicentre expansion cohort to evaluate imgatuzumab in pre-treated patients with KRAS-mutant advanced colorectal carcinomaDELORD, Jean-Pierre; TABERNERO, Josep; OPPENHEIM, David et al.European journal of cancer (1990). 2014, Vol 50, Num 3, pp 496-505, issn 0959-8049, 10 p.Article

Randomized Phase III Study Comparing Paclitaxel/Cisplatin/ Gemcitabine and Gemcitabine/Cisplatin in Patients With Locally Advanced or Metastatic Urothelial Cancer Without Prior Systemic Therapy: EORTC Intergroup Study 30987BELLMUNT, Joaquim; VON DER MAASE, Hans; WINQUIST, Eric et al.Journal of clinical oncology. 2012, Vol 30, Num 10, pp 1107-1113, issn 0732-183X, 7 p.Article

Risk-adapted management for patients with clinical stage I seminoma : The second spanish germ cell cancer cooperative group studyAPARICIO, Forge; GERMA, José R; BASTUS, Roma et al.Journal of clinical oncology. 2005, Vol 23, Num 34, pp 8717-8723, issn 0732-183X, 7 p.Article

Randomized phase II feasibility study of combining the matrix metalloproteinase inhibitor BMS-275291 with paclitaxel plus carboplatin in advanced non-small cell lung cancerDOUILLARD, Jean-Yves; PESCHEL, Christian; HUMPHREY, Jeffrey et al.Lung cancer. 2004, Vol 46, Num 3, pp 361-368, issn 0169-5002, 8 p.Article

Update from the Spanish Oncology Genitourinary Group on the treatment of advanced renal cell carcinoma: focus on special populationsCALVO, Emiliano; MAROTO, Pablo; DEL MURO, Xavier García et al.Cancer metastasis reviews. 2010, Vol 29, issn 0167-7659, S11-S20, SUP1Article

Phase I Clinical and Pharmacokinetic Study of Kahalalide F Administered Weekly as a 1-Hour Infusion to Patients with Advanced Solid TumorsPARDO, Beatriz; PAZ-ARES, Luis; IZQUIERDO, Miguel Angel et al.Clinical cancer research. 2008, Vol 14, Num 4, pp 1116-1123, issn 1078-0432, 8 p.Article

Phase I Pharmacokinetic/Pharmacodynamic Study of EKB-569, an Irreversible Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Combination with Irinotecan, 5-Fluorouracil, and Leucovorin (FOLFIRI) in First-LineTreatment of Patients with Metastatic Colorectal CancerFOLPRECHT, Gunnar; TABERNERO, Josep; LEJEUNE, Chantal et al.Clinical cancer research. 2008, Vol 14, Num 1, pp 215-223, issn 1078-0432, 9 p.Article

Phase III study of gemcitabine and cisplatin with or without aprinocarsen, a protein kinase C-alpha antisense oligonucleotide, in patients with advanced-stage non-small-cell lung cancerPAZ-ARES, Luis; DOUILLARD, Jean-Yves; LAHN, Michael et al.Journal of clinical oncology. 2006, Vol 24, Num 9, pp 1428-1434, issn 0732-183X, 7 p.Article

Incidence of contralateral germ cell testicular tumors in South Europe: Report of the experience at 2 Spanish university hospitals and review of the literatureTABERNERO, Josep; PAZ-ARES, Luis; SALAZAR, Ramon et al.The Journal of urology. 2004, Vol 171, Num 1, pp 164-167, issn 0022-5347, 4 p.Article

Spinophilin Loss Correlates with Poor Patient Prognosis in Advanced Stages of Colon CarcinomaESTEVEZ-GARCIA, Purificacion; LOPEZ-CALDERERO, Iker; CARNERO, Amancio et al.Clinical cancer research (Print). 2013, Vol 19, Num 14, pp 3925-3935, issn 1078-0432, 11 p.Article

Strategies for improving outcomes in NSCLC: A look to the futureSTAHEL, Rolf; PETERS, Solange; PAZ-ARES, Luis et al.Lung cancer. 2013, Vol 82, Num 3, pp 375-382, issn 0169-5002, 8 p.Article

Complete Longitudinal Analyses of the Randomized, Placebo-Controlled, Phase III Trial of Sunitinib in Patients with Gastrointestinal Stromal Tumor following Imatinib FailureDEMETRI, George D; GARRETT, Christopher R; PAZ-ARES, Luis et al.Clinical cancer research (Print). 2012, Vol 18, Num 11, pp 3170-3179, issn 1078-0432, 10 p.Article

Randomized Phase III Trial of Paclitaxel/Carboplatin With or Without PF-3512676 (Toll-Like Receptor 9 Agonist) As FirstLine Treatment for Advanced Non―Small-Cell Lung CancerHIRSH, Vera; PAZ-ARES, Luis; BAJETTA, Emilio et al.Journal of clinical oncology. 2011, Vol 29, Num 19, pp 2667-2674, issn 0732-183X, 8 p.Article

Pretreatment prognostic factors for survival in patients with advanced urothelial tumors treated in a Phase I/II trial with paclitaxel, cisplatin, and gemcitabineBELLMUNT, Joaquim; ALBANELL, Joan; BASELGA, José et al.Cancer. 2002, Vol 95, Num 4, pp 751-757, issn 0008-543XArticle

Maintenance treatment of advanced non-small-cell lung cancer: Results of an International Expert Panel Meeting of the Italian Association of Thoracic OncologyGRIDELLI, Cesare; DE MARINIS, Filippo; PIRKER, Robert et al.Lung cancer. 2012, Vol 76, Num 3, pp 269-279, issn 0169-5002, 11 p.Article